	Cisplatin sensitivity and resistance
Epidermal growth factor receptor (EGFR)
Oral squamous cell carcinoma (OSCC)
EGFR inhibitor
Cisplatin-resistant OSCC cell line
	cell lines
cisplatin resistance
oral squamous cell carcinoma
cisplatin
EGFR inhibitors
EGFR
cells
combination
oral cancers
OSCC cell growth
study
pEGFR
inhibition
pathways
tumors
Sa3 line
cisplatin sensitivity
intrinsic resistance
Higher expression
concentrations
cancer therapy
proteins
downstream
effects
treatment
addition
OSCC
sensitivity
growth

